Scientists are testing potential hypothyroidism treatment

Hypothyroidism is a common endocrine condition. Individuals typically manage this disease through supplementation with synthetic thyroid hormone, in order to alleviate symptoms and restore normal thyroid stimulating hormone levels, 7th Space reports.

This management strategy is usually effective and well tolerated. However, there is research to suggest that a significant proportion of hypothyroid sufferers are inadequately managed. Furthermore, hypothyroid patients are more likely to have a decreased sense of well-being and more commonly experience constitutional and neuropsychiatric complaints.

Within the chiropractic industry, there is growing support for the use of a biopsychosocial-based intervention called Neuro-Emotional Technique (NET) for these individuals.

Scientists are currently conducting a study in order to test the efficacy of this treatment. A sample of 102 adults who meet the inclusion criteria will be treated with NET or a placebo. The researchers will measure serum thyroid stimulating hormone, serum free-thyroxine, serum free-triiodothyronine, serum thyroid peroxidase auto-antibodies, serum thyroglobulin auto-antibodies as well as the measurement of functional health and well-being.

An estimated 450,000 thyroid biopsies are performed each year in the U.S., according to the American Cancer Society.